載入...
Profile of bevacizumab and its potential in the treatment of cervical cancer
Blocking angiogenesis is an effective antitumor strategy proven in many disease sites. Anti-angiogenic therapies are fulfilling the promise of improved outcomes in cervical cancer as demonstrated in several recent trials. With its overall survival improvement in metastatic or recurrent cervical canc...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4657807/ https://ncbi.nlm.nih.gov/pubmed/26640382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S73251 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|